Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Herbatia Sari Asi is a herbal dietary supplement developed and marketed by PT Tunggal (Tunggal Idaman Abdi) in Indonesia. It is specifically formulated as a galactagogue to support and enhance breast milk production in lactating women. The product contains a combination of two standardized herbal extracts: *Sauropus androgynus* (Katuk) leaf extract and *Trigonella foenum-graecum* (Fenugreek) seed extract. *Sauropus androgynus* is a traditional Southeast Asian medicinal plant believed to stimulate prolactin synthesis, while Fenugreek is a globally recognized herbal stimulant for milk production, potentially acting through phytoestrogens and stimulation of the mammary glands. Herbatia Sari Asi is available as an over-the-counter (OTC) capsule and is categorized as a Standardized Herbal Medicine (Obat Herbal Terstandar) in its home market.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Herbatia Sari Asi.